ABSTRACT A model was developed that characterized the maturation and growth of the renal function parameters (RFPs) glomerular filtration rate (GF), active tubular secretion (AS), and renal plasma flow (Q R ).
where W is body weight, k mat is the maturation rate constant, b is the body weight exponent, and a and c are RFP im and RFP ma at unit W. The model-based equation was fitted to the age-W, RFP values by a nonlinear least-squares method. For GF, the maturation half-life was 7.9 months (90% maturation, 26 months), the body weight exponent was 0.662, and the ratio c/a (which reflected the magnitude of the maturation influence) was 3.1. For AS and Q R , the maturation half-lives were about 3.8 months and the ratio c/a was about 1.8. For renally eliminated drugs, the model can be used to estimate dosing regimens that are based on the adult dosing regimen and the age and weight of the child.
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INTRODUCTION Dosing regimens are usually devised to maintain the drug plasma concentration within the therapeutic window 1 . The dosing regimen is commonly based on the product of the total body clearance and the desired plasma concentration. Although the total body clearances of most drugs are available for adults 2 , there is little quantitative information about clearance values in infants and children 3 . Consequently, when drug clearance values are unknown in the pediatric patient, the suggested dosing rate is the product of the adult dosing rate (DR) and the fraction of the adult body surface area (BSA) of the child; ie, DR child = 1. 4 4 . Implicit in this calculation is the assumption that the total body clearance of the drug is directly proportional to the body surface area in adults and children; ie, proportional to body weight to the twothirds power.
For renally eliminated drugs, clearance values in children follow the body surface area relationship reasonably well, although caution is recommended for very young children because clearance mechanisms are thought to be immature at birth, and the immaturity is thought to persist for several months until the adult clearance capacity is achieved 5 . For example, the influence of immaturity was apparent in the total body clearance values for the renally eliminated antibiotic cefetamet 6 . The expected linear relationship between clearance and body weight on log-log coordinates was observed for children above the age of 4 years, but the clearance values in younger children deviated negatively from the line.
Although both maturation and growth are involved in the age-associated increase in renal clearance capacity, there has been no analysis that shows quantitatively the individual influences of the 2 processes. In this report, a model that separately accounted for maturation and growth influences was applied to renal function parameters from the literature.
MATERIALS AND METHODS

Renal Function Parameters
Values for glomerular filtration rate (GF), active tubular secretion (AS), and renal plasma flow (Q R ) were from Rubin et al, in which cross-sectional data were reported from 63 normal well children between the ages of 2 days and 12 years 7 . GF was the mannitol clearance, which was determined by intravenous injection of mannitol and removal of at least 3, and usually 4, serial blood samples beginning at 20 minutes postinjection. When plotted versus time on semilogarithmic coordinates, the plasma concentrations of mannitol fell along a straight line. The plasma concentration at the midpoint of serial urine collections minus 2 minutes was interpolated from the plot and used along with the amount of mannitol in the urine sample to calculate the clearance, from the relationship GF = excretion rate of mannitol divided by its plasma concentration. At least 2 and generally 3 or 4 successive estimations of GF were made and averaged to make the final GF value for each subject.
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William L. Hayton Telephone: (614) 292-1288 Facsimile: (614)292-7766 E-mail: hayton.1@osu.edu Q R was determined simultaneously with GF, by administration of a low dose of p-aminohippuric acid (PAH) with the mannitol and determination of its renal clearance, which was taken as a measure of Q R . AS was determined as the renal clearance of PAH after a high dose. The maximum rate of PAH renal elimination was determined and the elimination of PAH by glomerular filtration was subtracted to give AS. Both Q R and AS were the averages of at least 2 and generally 3 or 4 serial determinations.
Model of Maturation and Growth
To discriminate among maturation and growth, a model that separated the 2 influences was used 6 . Each renal function parameter (RFP) was assumed to have at birth an immature value (RFP im ) that increased exponentially with age to the mature value (RFP ma ) (Figure 1) . The maturation part of the model assumed the following RFP-age relationship:
RFP(age) = RFP im e -kmat*age + RFP ma (1 -e -kmat*age ).
[Equation 1]
The first-order rate constant k mat determined the rate at which RFP im approached RFP ma . To incorporate the influence of body weight, both RFP im and RFP ma were assumed to follow the allometric equation 8 . The body weight exponent (b) value in Equations 2 and 3, which related RFP im and RFP ma to body weight (W), was assumed to be the same for both:
where a and c are the values of RFP im and RFP ma at unit body weight. 
Estimation of Model Parameters
Values of the RFPs appeared to increase with age as a consequence of maturation of renal function, as well as increased body size (see Results). Equation 4 was fitted by nonlinear least squares to RFP values determined in 63 subjects that ranged in age from 2 days to 142 months and in body weight from 2.15 to 35.5 kg. The WinNonlin computer program, ver. 1.1 (Scientific Consulting, Lexington, KY), was used. Both age and body weight were independent variables; the parameters were a, b, c, and k mat , and the weighting function was Y -2 . 
RESULTS
When the RFPs were plotted versus body weight on loglog coordinates, the relationships appeared linear for the older children. For example, Figure 2 shows GF values and the linear regression line (solid line) for age above 2 years. Values from children below the age of 2 years generally fell below the extrapolated line based on the GF values from the older children, and this negative deviation was attributed to immaturity of GF function. Table 1 and average weight for age values from Table 2 . The fit of Equation 4 to the observed GF values was not displayed here because the equation used 2 independent variables (age and weight), and both of them could not be displayed. The points appeared to scatter randomly about the line of identity for the entire data set, although several of the points appeared to be displaced significantly from the line. Of the 63 points shown, 33 lay within ±15% of the line, 18 lay between ±15% to ±25%, and 12 were displaced more than ±25% from the corresponding line value. The displacement of the points from the line reflects unaccounted for factors in addition to maturation Table  1 . Also shown in Figure 2 (dashed line) are the GF values predicted for average weight for age subjects. 
Table 1. Model parameter values ±CV%* from the least-squares fit of the maturation-growth model (Equation 4) to glomerular filtration rate (GF), active tubular secretion activity (AS), and renal blood flow (QR)
DISCUSSION
The discovery of a method to normalize renal function over the preadult period has important practical implications for the development of dosing regimens for renally cleared drugs. Rubin et al examined the RFPs used here in regard to body weight, body height, body surface area, average kidney weight, and average basal metabolic rate. None of these factors individually accounted for the changes observed in infants and children 7 . Hallynck et al examined a compilation of creatinine clearances from 5,146 normal subjects (from 68 publications) ranging in age over the entire life span 9 . Normalization to body weight, lean body mass, and body surface area did not produce a unifying value for this parameter. More recently, linear regression techniques were used to develop an empirical mathematical model that related GF to age and weight 10 . Although this model predicted GF using the age and weight of the subject, it failed to "disentangle" age and weight 11 and did not provide insight into the kinetics of maturation as separate from the kinetics of growth.
The model presented here separates and quantifies the influence of maturation from the influence of growth on the RFPs. The degree of maturation of the RFPs is indicated by the ratio c:a, which was 3.1 for GF, as contrasted with 1.7 and 1.9 for AS and QR ( Table 1 ). In the absence of growth, the renal clearance capacities of filtration and active secretion (intrinsic transport capacity and flow-limited capacity) would increase by these factors, with increasing age attributable solely to maturation. In other words, the GF capacity per unit body weight at birth was 32% of the mature capacity. The time for maturation, as characterized by the maturation half-life, can be taken as 3.3 t 1/2,mat (time for 90% maturation), or about 2 years for GF and 1 year for AS and Q R .
The body weight exponent, b, for growth of GF was near the value of two thirds, which suggested that GF growth paralleled the body surface area. In contrast, b-values for AS and Q R were near 1, and growth of active secretion, therefore, appeared to parallel body weight.
To examine the influences of maturation and growth on the RFPs, average body weights for age were taken from the literature 12 ( Table 2) . Values for male and female subjects were similar and averaged. These age and weight values were used with the parameters shown in Table 1 to calculate with Equation 4 the value of each RFP as a function of age ( Table 2 ) and for GF ( Figure  2 ). When these values were expressed per kg body weight and divided by the corresponding modelpredicted young-adult values (W = 70 kg, age = 240 months), the profiles in Figure 6 were obtained. The fractional GF was near 1 at birth; ie, GF per kg body weight was near the young-adult value at birth. Subsequently, GF was influenced positively by maturation and negatively by growth, over 2 time frames. Maturation had the greater influence initially, with the GF per kg exceeding the young-adult value by nearly 70% at 30 months. The influence of maturation ended at this age while growth contined to exert its negative influence, which resulted in the decline of GF per kg to the youngadult value. Both maturation and growth acted oppositely and simultaneously during the first 2 years of life, and their net influence is apparent in Figure 6 . Table 2 . Model-predicted values for glomerular filtration rate (GF), active secretion activity (AS), and renal plasma flow (QR) in average-weight-for-age neonates, infants, and children Table 3 . Usual adult (55 years, 70 kg) dosing rate adjustment factor for renally eliminated drugs that have a high therapeutic index Figure 6 .Model-predicted RFP per kg body weight as a fraction of the model-predicted young-adult value for average-weight-for-age children.
The profiles for AS and Q R differ from that of GF ( Figure  6 ). These RFPs per kg body weight were about half the young-adult values at birth, and they more rapidly assumed their young-adult values: AS by 12 months and Q R by 3.5 months.
Recent concern has been expressed about the small fraction of drugs approved for use in children, even though many drugs lacking approval for children are widely used 13 . A 1999 FDA rule requires pediatric studies to generally support use of drugs in children 14 . For drugs that lack specific dosage guidelines for infants and children, the results of the analysis in this paper may be used to adapt the adult dosing regimen when the drug is renally eliminated. Multiple dosing regimens are usually based on the total body clearance such that the dosing rate is taken as the product of the clearance and the desired steady-state plasma concentration of the drug. For renally eliminated drugs, it is well accepted that the renal clearance is proportional to GF 15 . In adults with impaired renal function, surrogate measures of GF (CL CR , S CR ) are often used to adjust the dosing rate. Extension of these concepts to adaptation of the adult regimen for the child leads to the proposition that the RFP values per kg in Table 2 , expressed as a fraction of the adult values, could be applied to the adult mg/kg regimen to estimate the appropriate mg/kg regimen for the child. For example, for a drug that was eliminated by glomerular filtration only, a 7-month-old child of average weight for age (8.12 kg) would have a model-predicted GF of 2.54 mL/minute/kg. Using the mature-adult GF of 100 mL/minute/70 kg or 1.43 mL/minute/kg indicates that the child should have a mg/kg dosing rate that is (2.54/1.43) or 1.78 times the mature-adult mg/kg dosing rate. If the weight of the child deviated from the average, a proportional adjustment should be made; eg, if W = 10 kg, then the adjustment should be 1.78 x (10/8.12) or 2.19 times the adult mg/kg dosing rate.
The above calculation used 100 mL/minute for the normal mature-adult GF. The GF predicted using Equation 4 for a young adult (70 kg, 20 yr) was 136 mL/minute or 1.94 mL/minute/kg, which was substantially above the value of 1.43 mL/minute/kg, although in line with population average GF values in young adults of 120 to 130 mL/minute. It has been suggested that the appropriate denominator for this calculation is the GF for the typical adult patient for whom the drug would most likely be prescribed; ie, 55 years of age and 70 kg. A GF value of 85 mL/minute/70 kg has been recommended 15 , but in view of the slightly elevated young-adult GF value predicted using Equation 4, the mature-adult GF value of 100 mL/minute/70 kg seemed appropriate.
This approach can be implemented by insertion of the parameter values for GF from Table 1 into Equation 4 , dividing through the equation by W and then division by 1.43 mL/minute/kg, followed by simplification to give FRAC GF , the fraction of the usual adult mg/kg dosing rate for a child: FRAC AS should be used in cases where the desired plasma concentration is well above the K M of the transporter, whereas FRAC QR should be used when the concentration is well below the K M . When both filtration and active tubular secretion contribute to the drug clearance, an appropriately weighted average of the FRAC GF and FRAC AS or FRAC QR fractions should be used. When a high therapeutic index provides a margin of safety, the adjustment factors in Table 3 should suffice.
